|Calculated MW||8.750 kDa|
|Other Names||Apolipoprotein CIII, apolipoprotein, apolipoproteins|
|Storage||-70°C; Frozen in 10 mM NH4HCO3 , pH 7.4|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake from plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin resistance. The normal plasma concentration of Apo CIII is 8-15 mg per 100 ml.
Protter A.A.,et al.DNA 3:449-456(1984).
Levy-Wilson B.,et al.DNA 3:359-364(1984).
Karathanasis S.K.,et al.J. Lipid Res. 26:451-456(1985).
Sharpe C.R.,et al.Nucleic Acids Res. 12:3917-3932(1984).
Fullerton S.M.,et al.Hum. Genet. 115:36-56(2004).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.